A rare patient has made it possible for researchers to prove that vitamin D—the "sun vitamin"—helps the body fight tuberculosis.

Newly published research from the University of Cincinnati finds that people with latent tuberculosis infection (LTBI) have more inflammation and could be at a higher risk for cardiovascular disease.

5 Jan 2023: Researchers from the South African Tuberculosis Vaccine Initiative (SATVI) have just published results from a study using cutting edge-technology to identify new targets for novel TB vaccine candidates.

Researchers have developed a novel genome assembly tool that could spur the development of new treatments for tuberculosis and other bacterial infections.

The World Health Organization releases updated guidelines and a supporting operational handbook on the treatment of drug-resistant TB featuring major improvements in treatment options for people with multidrug-resistant or rifampicin-resistant TB.

Company receives $14.2M in grants from the Bill & Melinda Gates Foundation to support the TB test’s ongoing development and future launch into developing countries.

Effective tuberculosis (TB) treatment has been available for the past 60 years. But TB remains the leading cause of death from a single infectious agent. It ranks above HIV and AIDS and others. This is partly because of the impact of HIV co-infection among TB patients in places like Africa and emergency of MDR-XDR TB. Lack of both gender mainstreaming and reduction of stigma manifested by persistently lower reported cases among women that men is of continued concern.

GFAN is selected to coordinate the Affected Communities and Civil Society Platform for the 2023 UN High-Level Meeting on TB. Applications are now being accepted for lead consultant(s) to support this work (Deadline: 5 January 2023).

Innovative TB Community Service Delivery during the COVID-19 Pandemic: Best Practices and Lessons Learned from Cambodia, India, Indonesia, and Kenya